Travers Smith partner Aaron Stocks and senior corporate associate Jon Reddington have advised 2IL Orthopaedics Limited on its successful recommended cash offer to acquire the entire issued and to be issued share capital of main market listed, Corin Group PLC, for a total consideration of approximately £30.5 million.

Corin Group PLC is a leading designer, manufacturer and distributor of orthopaedics products which has pioneered a number of landmark orthopaedic developments since being established in 1985. Corin's portfolio of products includes the Cormet, Trinity, MiniHip and MetaFix hip replacement technologies as well as the Uniglide, Unity Knee and Rotaglide knee replacement systems. Corin's wider portfolio includes the Zenith total ankle replacement system and the LARs soft tissue treatment options. Using its own sales teams combined with a global network of trusted distributors, Corin supplies the orthopaedic market throughout the world.

2IL Orthopaedics Limited believes that the acquisition of Corin represents an attractive opportunity due to its brand position in the market and its product portfolio; its existing direct global sales operation, distributor network and customer relationships; and its potential as a platform for further growth, both organically and through acquisition.

Commenting on the transaction, Aaron Stocks said, "We are delighted to have acted for 2IL Orthopaedics Limited on its recommended cash offer for Corin Group PLC and look forward to working with 2IL and Corin going forward." 

Panmure Gordon (UK) Limited acted as financial adviser to 2IL Orthopaedics Limited. Rothschild acted as financial adviser to Corin Group PLC.